School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
Department of Clinical Pharmacology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Neurosurg Rev. 2022 Apr;45(2):1521-1531. doi: 10.1007/s10143-021-01665-4. Epub 2021 Oct 18.
Intracranial aneurysms (IAs) remain a major public health concern and endovascular treatment (EVT) has become a major tool for managing IAs. However, the recurrence rate of IAs after EVT is relatively high, which may lead to the risk for aneurysm re-rupture and re-bleed. Thus, we aimed to develop and assess prediction models based on machine learning (ML) algorithms to predict recurrence risk among patients with IAs after EVT in 6 months. Patient population included patients with IAs after EVT between January 2016 and August 2019 in Hunan Provincial People's Hospital, and an adaptive synthetic (ADASYN) sampling approach was applied for the entire imbalanced dataset. We developed five ML models and assessed the models. In addition, we used SHapley Additive exPlanations (SHAP) and local interpretable model-agnostic explanation (LIME) algorithms to determine the importance of the selected features and interpret the ML models. A total of 425 IAs were enrolled into this study, and 66 (15.5%) of which recurred in 6 months. Among the five ML models, gradient boosting decision tree (GBDT) model performed best. The area under curve (AUC) of the GBDT model on the testing set was 0.842 (sensitivity: 81.2%; specificity: 70.4%). Our study firstly demonstrated that ML-based models can serve as a reliable tool for predicting recurrence risk in patients with IAs after EVT in 6 months, and the GBDT model showed the optimal prediction performance.
颅内动脉瘤(IAs)仍然是一个主要的公共卫生问题,血管内治疗(EVT)已成为治疗 IAs 的主要手段。然而,EVT 后 IAs 的复发率相对较高,这可能导致动脉瘤再次破裂和再出血的风险。因此,我们旨在开发和评估基于机器学习(ML)算法的预测模型,以预测 EVT 后 6 个月内 IAs 患者的复发风险。患者人群包括 2016 年 1 月至 2019 年 8 月期间在湖南省人民医院接受 EVT 的 IAs 患者,对整个不平衡数据集应用自适应综合(ADASYN)采样方法。我们开发了五个 ML 模型并对其进行了评估。此外,我们使用 SHapley Additive exPlanations(SHAP)和局部可解释模型不可知解释(LIME)算法来确定所选特征的重要性并解释 ML 模型。共有 425 个 IAs 纳入本研究,其中 66 个(15.5%)在 6 个月内复发。在五个 ML 模型中,梯度提升决策树(GBDT)模型表现最佳。GBDT 模型在测试集上的曲线下面积(AUC)为 0.842(灵敏度:81.2%;特异性:70.4%)。本研究首次表明,基于 ML 的模型可以作为预测 EVT 后 6 个月内 IAs 患者复发风险的可靠工具,GBDT 模型显示出最佳的预测性能。